NASDAQ:NAMS | Operating Income | NewAmsterdam Pharma Co N.V.

Complete source-backed operating income history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$64.86M
2026-03-31-$58.42M
2025-12-31-$65.98M
2025-09-30-$55.14M
2025-06-30-$35.64M
2025-03-31-$68.93M
2024-12-31-$43.23M
2024-09-30-$25M
2024-06-30-$52.58M
2024-03-31-$55.48M
2023-12-31-$51.07M
2023-09-30-$49.56M
2023-06-30-$42.48M
2023-03-31-$39.85M

Annual Operating Income

DateOperating Income
2025-12-31-$225.68M
2024-12-31-$176.29M
2023-12-31-$182.97M
2022-12-31-$3.56M
2021-12-31-$34.98M